CXCL1 and granular corneal dystrophy type II: Our research group has reported much research about SADBE-induced ACD; we will further validate whether RANKL protects humans from ACD, or ACD downregulates IL9 and upregulates the expression of GROα, TRAIL, C4, and Complement factor B.